Jakob Knudsen
Directeur Général chez VIROGATES A/S
Fortune : 116 241 $ au 30/04/2024
Postes actifs de Jakob Knudsen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Directeur/Membre du Conseil | 01/04/2017 | - |
| Independent Dir/Board Member | 01/04/2017 | - | |
| VIROGATES A/S | Directeur Général | 01/04/2011 | - |
| Investor Relations Contact | - | - | |
ExpreS2ion Biotechnologies ApS
 ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Directeur/Membre du Conseil | - | - |
| Independent Dir/Board Member | - | - | |
| P.V. Fonden | Directeur/Membre du Conseil | - | - |
| Ingeniørsystem A/S | Directeur/Membre du Conseil | - | - |
| Jakob Knudsen Enkeltmandsvirksomhed | Directeur/Membre du Conseil | - | - |
Historique de carrière de Jakob Knudsen
Anciens postes connus de Jakob Knudsen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Egalet Ltd.
 Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | Directeur Financier/CFO | 01/02/2008 | 01/04/2011 |
| ALK-ABELLÓ A/S | Corporate Officer/Principal | 01/09/1999 | 01/02/2008 |
Formation de Jakob Knudsen
| Imperial College London | Masters Business Admin |
| University of Copenhagen | Graduate Degree |
Statistiques
Internationale
| Danemark | 9 |
| Royaume-Uni | 3 |
Opérationnelle
| Director/Board Member | 5 |
| Independent Dir/Board Member | 2 |
| Director of Finance/CFO | 1 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ALK-ABELLÓ A/S | Health Technology |
| VIROGATES A/S | Health Technology |
| EXPRES2ION BIOTECH HOLDING AB | Health Technology |
| Entreprise privées | 5 |
|---|---|
Egalet Ltd.
Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | Health Technology |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Health Technology |
| Ingeniørsystem A/S | |
| P.V. Fonden | |
| Jakob Knudsen Enkeltmandsvirksomhed |
- Bourse
- Insiders
- Jakob Knudsen
- Expérience
